Tobradex ST: payments to doctors
Payments that named Tobradex ST as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $577K
- Providers
- 4,197
- Transactions
- 6,979
- Average per transaction
- $83
The per-transaction average — $83 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4,197 providers the average total is $138, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Eyevance Pharmaceuticals LLC | $562,677 | 97.5% |
| Harrow Eye, LLC | $14,718 | 2.5% |